Should we rely on trials with disease- rather than patient-oriented endpoints?

Harm-Jan de Grooth; Jean-Jacques Parienti; Heleen M Oudemans-van Straaten

doi:10.1007/s00134-017-4859-0

Should we rely on trials with disease- rather than patient-oriented endpoints?

Harm-Jan de Grooth^*, Jean-Jacques Parienti, Heleen M Oudemans-van Straaten

^*Corresponding author for this work

Research output: Contribution to journal › Letter › Academic › peer-review

Original language	English
Pages (from-to)	464-466
Number of pages	3
Journal	Intensive Care Medicine
Volume	44
Issue number	4
DOIs	https://doi.org/10.1007/s00134-017-4859-0
Publication status	Published - Apr 2018
Externally published	Yes

Keywords

Biomedical Research
Clinical Trials as Topic/standards
Critical Care
Endpoint Determination
Health Status Indicators
Humans
Organ Dysfunction Scores
Patient Outcome Assessment
Patient Reported Outcome Measures
Quality of Life
Survival Analysis
Treatment Outcome

Access to Document

10.1007/s00134-017-4859-0Licence: CC BY-NC

Cite this

@article{7b1db387dd3a46a98f948336ebfdf26a,

title = "Should we rely on trials with disease- rather than patient-oriented endpoints?",

keywords = "Biomedical Research, Clinical Trials as Topic/standards, Critical Care, Endpoint Determination, Health Status Indicators, Humans, Organ Dysfunction Scores, Patient Outcome Assessment, Patient Reported Outcome Measures, Quality of Life, Survival Analysis, Treatment Outcome",

author = "{de Grooth}, Harm-Jan and Jean-Jacques Parienti and {Oudemans-van Straaten}, {Heleen M}",

year = "2018",

month = apr,

doi = "10.1007/s00134-017-4859-0",

language = "English",

volume = "44",

pages = "464--466",

journal = "Intensive Care Medicine",

issn = "0342-4642",